Main > > >HYPERKALEMIA.

---

Critical Care Medicine>HyperKalemia. TREAT.: Na Zr CycloSilicate.
- Cardiovascular:
risk of hyperkalaemia increases for
patients who take common medications
for heart failure (HF), such as renin-
angiotensin-aldosterone system (RAAS)
inhibitors, which can increase
potassium in the blood.
- Metabolic.
- Renal (Nephrology):
risk of hyperkalaemia increases
significantly for patients with
chronic kidney disease (CKD)
EU Approval Date: 2018. 03.22.
USA Approval Date: 2018. 05.18.
(*) Company; Patents & TradeMark Avai-
lable on Request.
UpDate: 2018. 05.22.




>HYPERKALEMIA.'s products
This section has no products